Supervised pelvic floor muscle training improves sexual function and diminishes sexual distress in women with multiple sclerosis

Supervised pelvic floor muscle training improves sexual function and diminishes sexual distress in women with multiple sclerosis: a randomized controlled study

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN67646109

Enrollment

Registered

2023-07-06

Start date

2021-09-01

Completion date

Unknown

Last updated

2024-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Supervised pelvic floor muscle training improves sexual function and diminishes sexual distress in women with multiple sclerosis Musculoskeletal Diseases

Interventions

The intervention included women suffering from MS with an EDSS score <4 and divided them into two groups. In Group A, women followed a program of supervised pelvic floor muscle training (PFMT) for 12

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: 1. 18 years of age or older 2. Diagnosis of relapsing-remitting MS 3. Stable condition for a minimum period of six months 4. Kurtzke’s Expanded Disability Status Scale (EDSS) score < 4 5. Women sexually active for at least four weeks 6. Cognitive ability to complete the questionnaires and study protocol 7. Ability to contract PFM evaluated by the primary investigator

Exclusion criteria

Exclusion criteria: 1. Previous pelvic floor muscle training program 2. Ongoing pregnancy 3. Child delivery within the previous six months 4. Urinary or faecal incontinence 5. Pelvic organ prolapses greater than stage I 6. Perimenopause or menopause period

Design outcomes

Primary

Measure	Time frame
Effect of pelvic floor muscle training (PFMT) on improving sexual function and sexual distress in women suffering from MS measured using the Female Sexual Function Index (FSFI) and the Female Sexual Distress Scale-Revised (FSDS-R) questionnaires scores at the beginning and end of the twelve-week study	—

Secondary

Measure	Time frame
There are no secondary outcome measures	—

Countries

Greece

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026